Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1ANTI-IL12/23 or ANTI-IL23 - ustekinumab----[1] 96 💬
2EX-vivo stimulation OF cells with infliximab, golimumab, adalimumab, vedolizumab and ustekinumab----[1] 97 💬
3Group 1 OF patients will receive adalimumab while group 1 will receive ustekinumab----[1] 97 💬
4Group 2 ustekinumab 130 MG----[2] 96, 97 💬
5Group 3: ustekinumab approximately 6 MG/KG----[2] 96, 97 💬
6Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab or tofacitinib[1] Infliximab[1] Infliximab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[2] 96, 97 💬
7Infliximab, adalimumab, golimumab, vedolizumab, ustekinumab[1] Infliximab[1] Infliximab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 97 💬
8PK-model TO decide when TO dose vedolizumab and ustekinumab----[2] 96, 97 💬
9Prednisone and ustekinumab treatment[1] Prednisone[1] Prednisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 41 💬
10Selective intensive induction therapy based ON ustekinumab clinical decision-making tools----[1] 96 💬
11Subcutaneous ustekinumab----[1] 56 💬
12Ustekinumab[1] Ustekinumab (Ustekinumab)[1] Ustekinumab (Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab-aauz, Ustekinumab-auub, Ustekinumab-ttwe, Ustekinumab-aekn, USTEKINUMAB, USTEKINUMAB-AEKN, USTEKINUMAB-TTWE) 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[16] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
13Ustekinumab - standard dosage[1] Ustekinumab (Ustekinumab)[1] Ustekinumab (Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab-aauz, Ustekinumab-auub, Ustekinumab-ttwe, Ustekinumab-aekn, USTEKINUMAB, USTEKINUMAB-AEKN, USTEKINUMAB-TTWE) 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[2] 96, 97 💬
14Ustekinumab 130 MG IV[1] Ustekinumab (Ustekinumab)[1] Ustekinumab (Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab-aauz, Ustekinumab-auub, Ustekinumab-ttwe, Ustekinumab-aekn, USTEKINUMAB, USTEKINUMAB-AEKN, USTEKINUMAB-TTWE) 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[2] 96, 97 💬
15Ustekinumab 180 MG[1] Ustekinumab (Ustekinumab)[1] Ustekinumab (Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab-aauz, Ustekinumab-auub, Ustekinumab-ttwe, Ustekinumab-aekn, USTEKINUMAB, USTEKINUMAB-AEKN, USTEKINUMAB-TTWE) 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 93 💬
16Ustekinumab 4.5 MG/KG[1] Ustekinumab (Ustekinumab)[1] Ustekinumab (Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab-aauz, Ustekinumab-auub, Ustekinumab-ttwe, Ustekinumab-aekn, USTEKINUMAB, USTEKINUMAB-AEKN, USTEKINUMAB-TTWE) 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
17Ustekinumab 45 MG[1] Ustekinumab (Ustekinumab)[1] Ustekinumab (Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab-aauz, Ustekinumab-auub, Ustekinumab-ttwe, Ustekinumab-aekn, USTEKINUMAB, USTEKINUMAB-AEKN, USTEKINUMAB-TTWE) 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 93 💬
18Ustekinumab 6 MG/KG[1] Ustekinumab (Ustekinumab)[1] Ustekinumab (Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab-aauz, Ustekinumab-auub, Ustekinumab-ttwe, Ustekinumab-aekn, USTEKINUMAB, USTEKINUMAB-AEKN, USTEKINUMAB-TTWE) 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 50 💬
19Ustekinumab 90 MG[1] Ustekinumab (Ustekinumab)[1] Ustekinumab (Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab-aauz, Ustekinumab-auub, Ustekinumab-ttwe, Ustekinumab-aekn, USTEKINUMAB, USTEKINUMAB-AEKN, USTEKINUMAB-TTWE) 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[5] 49, 50, 93, 96, 97 💬
20Ustekinumab 90 MG (SC) group 1[1] Ustekinumab (Ustekinumab)[1] Ustekinumab (Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab-aauz, Ustekinumab-auub, Ustekinumab-ttwe, Ustekinumab-aekn, USTEKINUMAB, USTEKINUMAB-AEKN, USTEKINUMAB-TTWE) 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
21Ustekinumab 90 MG (SC) group 2[1] Ustekinumab (Ustekinumab)[1] Ustekinumab (Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab-aauz, Ustekinumab-auub, Ustekinumab-ttwe, Ustekinumab-aekn, USTEKINUMAB, USTEKINUMAB-AEKN, USTEKINUMAB-TTWE) 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
22Ustekinumab 90 MG SC Q12W[1] Ustekinumab (Ustekinumab)[1] Ustekinumab (Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab-aauz, Ustekinumab-auub, Ustekinumab-ttwe, Ustekinumab-aekn, USTEKINUMAB, USTEKINUMAB-AEKN, USTEKINUMAB-TTWE) 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[2] 96, 97 💬
23Ustekinumab 90 MG SC Q8W[1] Ustekinumab (Ustekinumab)[1] Ustekinumab (Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab-aauz, Ustekinumab-auub, Ustekinumab-ttwe, Ustekinumab-aekn, USTEKINUMAB, USTEKINUMAB-AEKN, USTEKINUMAB-TTWE) 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[2] 96, 97 💬
24Ustekinumab and semi enteral nutrition[1] Ustekinumab (Ustekinumab)[1] Ustekinumab (Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab-aauz, Ustekinumab-auub, Ustekinumab-ttwe, Ustekinumab-aekn, USTEKINUMAB, USTEKINUMAB-AEKN, USTEKINUMAB-TTWE) 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
25Ustekinumab and upadacitinib[1] Ustekinumab (Ustekinumab)[1] Ustekinumab (Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab-aauz, Ustekinumab-auub, Ustekinumab-ttwe, Ustekinumab-aekn, USTEKINUMAB, USTEKINUMAB-AEKN, USTEKINUMAB-TTWE) 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 96 💬
26Ustekinumab dose based ON BSA and body weight[1] Ustekinumab (Ustekinumab)[1] Ustekinumab (Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab-aauz, Ustekinumab-auub, Ustekinumab-ttwe, Ustekinumab-aekn, USTEKINUMAB, USTEKINUMAB-AEKN, USTEKINUMAB-TTWE) 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 97 💬
27Ustekinumab injection[1] Ustekinumab (Ustekinumab)[1] Ustekinumab (Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab-aauz, Ustekinumab-auub, Ustekinumab-ttwe, Ustekinumab-aekn, USTEKINUMAB, USTEKINUMAB-AEKN, USTEKINUMAB-TTWE) 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 160 💬
28Ustekinumab IV[1] Ustekinumab (Ustekinumab)[1] Ustekinumab (Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab-aauz, Ustekinumab-auub, Ustekinumab-ttwe, Ustekinumab-aekn, USTEKINUMAB, USTEKINUMAB-AEKN, USTEKINUMAB-TTWE) 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[2] 49, 97 💬
29Ustekinumab IV infusion[1] Ustekinumab (Ustekinumab)[1] Ustekinumab (Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab-aauz, Ustekinumab-auub, Ustekinumab-ttwe, Ustekinumab-aekn, USTEKINUMAB, USTEKINUMAB-AEKN, USTEKINUMAB-TTWE) 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[2] 96, 97 💬
30Ustekinumab liquid IN prefilled syringe[1] Ustekinumab (Ustekinumab)[1] Ustekinumab (Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab-aauz, Ustekinumab-auub, Ustekinumab-ttwe, Ustekinumab-aekn, USTEKINUMAB, USTEKINUMAB-AEKN, USTEKINUMAB-TTWE) 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[1] 84 💬
31Ustekinumab SC[1] Ustekinumab (Ustekinumab)[1] Ustekinumab (Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab-aauz, Ustekinumab-auub, Ustekinumab-ttwe, Ustekinumab-aekn, USTEKINUMAB, USTEKINUMAB-AEKN, USTEKINUMAB-TTWE) 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[2] 49, 97 💬
32Ustekinumab SC injection[1] Ustekinumab (Ustekinumab)[1] Ustekinumab (Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab, Ustekinumab-aauz, Ustekinumab-auub, Ustekinumab-ttwe, Ustekinumab-aekn, USTEKINUMAB, USTEKINUMAB-AEKN, USTEKINUMAB-TTWE) 💬 [3] IL12A,
IL12B,
IL23A 💬 		[28] African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬[2] 96, 97 💬
33Vedolizumab, ustekinumab, or tofacitinib[1] Vedolizumab[1] Vedolizumab 💬 [2] ITGA4,
ITGB7 💬 		[16] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[1] 97 💬